Please Wait.....
Report
Dominican Republic Infusion Therapy Market
Market Report I 2025-11-01 I 350 Pages I Data Bridge Market Research
Dominican Republic Infusion Therapy market is expected to reach USD 281.15 Million by 2032 from USD 168.32 Million in 2024, growing with a CAGR of 6.7% in the forecast period of 2025 to 2032.
Market Segmentation:
Dominican Republic Infusion Therapy market, By Product Type (Equipment, Accessories and Component), Application (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy, Pediatrics/Neonatology, Hematology, Gastroenterology and Others.), Type (traditional infusion pumps and specialty infusion pumps), Usage (Disposable and Reusable), Infusion Method(intravenous, arterial, subcutaneous and epidural), Infusion Type(continuous infusion and intermittent infusion), Operation Type(syringe pump, Elastomeric Pump ,Peristaltic Pump , Multi-Channel Pump and Smart Pump) ,End User (Clinics and Hospitals, Home Healthcare, Ambulatory And Surgical Centers and others), Distribution Channel (Direct Tender, Retail Sales and Others) - Industry Trends and Forecast to 2032
Overview of Dominican Republic Infusion Therapy market Dynamics :
Driver
- Rising Prevalence Of Chronic Diseases
- Technological Advancements In Infusion Equipment
- Expansion Of Home Infusion Services
- Government Initiatives And Healthcare Investment
Restraint
- High Cost Of Infusion Equipment And Consumables
- Shortage Of Trained Healthcare Professionals
Opportunity
- Expansion Of Home Infusion Therapy Services
- Rising Medical Tourism In The Dominican Republic
- Adoption Of Technologically Advanced Infusion Devices
Challenges
- Limited Access To Healthcare In Rural Areas
- High Treatment Costs And Limited Insurance Coverage
Market Players:
The key market players operating in the Dominican Republic Infusion Therapy market are listed below:
- Fresenius Kabi AG (Germany)
- GE Healthcare (U.S.)
- Medtronic (Ireland)
- BAXTER (U.S.)
- ICU Medical (U.S.)
- B. Braun SE (Germany)
- Apothecaries Sundries Mfg. Pvt. Ltd (India)
- Terumo Corporation (Japan)
- KORU Medical Systems (USA)
- Farmaconol (Ireland)
- Changsha Skyfavor Medical Devices (China)
- Ariss Medical Inc. (U.S.)
- Grupo Hospifar (U.S.)
- BD (U.S.)
- Micrel Medical Devices SA (Greece)
- SternMed GmbH (Germany)
- Teleflex Incorporated (U.S.)
- Global Health (Dominican Republic)
- EPSIMED (U.S.)
- KALSTEIN FRANCE - SIREN (France)
- medzell (Eightwe Digital Transforma) (India)
- INSUMEDRD (Dominican Republic)
- Hunan Beyond Medical Technology (China)
- Avante (U.S.)
- Naugra Medical Lab (India)
- Jaincolab (India)
- Vygon (France)
TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF DOMINICAN REPUBLIC INFUSION THERAPY MARKET 15
1.4 LIMITATIONS 18
1.5 MARKETS COVERED 18
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 21
2.4 CURRENCY AND PRICING 21
2.5 DBMR TRIPOD DATA VALIDATION MODEL 22
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.7 MULTIVARIATE MODELLING 26
2.8 DBMR MARKET POSITION GRID 27
2.9 VENDOR SHARE ANALYSIS 28
2.10 MARKET END-USER COVERAGE GRID 29
2.11 SECONDARY SOURCES 30
2.12 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 38
4.1 PORTER'S FIVE FORCES 39
4.1.1 THREAT OF NEW ENTRANTS 39
4.1.2 BARGAINING POWER OF SUPPLIERS 39
4.1.3 BARGAINING POWER OF BUYERS 40
4.1.4 THREAT OF SUBSTITUTES 40
4.1.5 COMPETITIVE RIVALRY 40
4.2 PESTLE ANALYSIS 41
4.2.1 POLITICAL FACTORS: 41
4.2.2 ECONOMIC FACTORS: 41
4.2.3 SOCIAL FACTORS: 41
4.2.4 TECHNOLOGICAL FACTORS: 42
4.2.5 ENVIRONMENTAL FACTORS: 42
4.2.6 LEGAL FACTORS: 42
4.3 INDUSTRY INSIGHT: DOMINICAN REPUBLIC INFUSION THERAPY MARKET 43
4.3.1 MARKET DYNAMICS 43
4.3.2 TECHNOLOGICAL ADVANCEMENTS 43
4.3.3 REGULATORY LANDSCAPE 43
4.3.4 ECONOMIC CONSIDERATIONS 43
4.3.5 MARKET OPPORTUNITIES 43
4.3.6 CONCLUSION 43
4.4 MARKET ACCESS 44
4.4.1 REGULATORY ENTRY PATHWAYS 44
4.4.2 PUBLIC HEALTH INSURANCE AND REIMBURSEMENT MECHANISMS 44
4.4.3 PRICING AND PROCUREMENT POLICIES 44
4.4.4 DISTRIBUTION AND SUPPLY CHAIN FRAMEWORK 44
4.4.5 HEALTH TECHNOLOGY ASSESSMENT AND INCLUSION CRITERIA 45
4.4.6 PRIVATE INSURANCE AND OUT-OF-POCKET MARKET 45
4.4.7 CONCLUSION 45
4.5 PIPELINE ANALYSIS - DOMINICAN REPUBLIC INFUSION THERAPY MARKET 46
4.5.1 PHASE DISTRIBUTION 46
4.5.2 KEY TRENDS IN THE EXPANDED PIPELINE 46
5 REGULATORY FRAMEWORK 48
5.1 PRODUCT CODES 48
5.2 CERTIFIED STANDARDS 48
5.3 SAFETY STANDARDS 49
5.3.1 STORAGE & INVENTORY MANAGEMENT 49
5.3.2 TRANSPORT & PRECAUTIONS 49
5.3.3 HAZARD IDENTIFICATION 50
6 MARKET OVERVIEW 51
6.1 DRIVER 53
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 53
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN INFUSION EQUIPMENT 53
6.1.3 EXPANSION OF HOME INFUSION SERVICES 54
6.1.4 GOVERNMENT INITIATIVES AND HEALTHCARE INVESTMENT 54
6.2 RESTRAINTS 55
6.2.1 HIGH COST OF INFUSION EQUIPMENT AND CONSUMABLES 55
6.2.2 SHORTAGE OF TRAINED HEALTHCARE PROFESSIONALS 55
6.3 OPPORTUNITIES 56
6.3.1 EXPANSION OF HOME INFUSION THERAPY SERVICES 56
6.3.2 RISING MEDICAL TOURISM IN THE DOMINICAN REPUBLIC 57
6.3.3 ADOPTION OF TECHNOLOGICALLY ADVANCED INFUSION DEVICES 57
6.4 CHALLENGES 58
6.4.1 LIMITED ACCESS TO HEALTHCARE IN RURAL AREAS 58
6.4.2 HIGH TREATMENT COSTS AND LIMITED INSURANCE COVERAGE 58
7 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY PRODUCT TYPE 59
7.1 OVERVIEW 60
7.2 EQUIPMENTS 63
7.2.1 INFUSION PUMPS 64
7.2.1.1 VOLUMETRIC INFUSION PUMPS 64
7.2.1.2 SYRINGE INFUSION PUMPS 64
7.2.1.3 ELASTOMERIC PUMPS 64
7.2.1.4 PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS 64
7.2.1.5 AMBULATORY INFUSION PUMPS 64
7.2.2 OTHERS 64
7.3 COMPONENTS 65
7.3.1 IV SETS 65
7.3.2 INFUSION ADMINISTRATION SETS 65
7.3.3 INFUSION CATHETERS 65
7.3.4 NEEDLELESS CONNECTORS 65
7.3.5 CANNULAS 65
7.3.6 TUBING & EXTENSION SETS 65
7.3.7 VALVES 65
7.4 ACCESSORIES 66
7.4.1 DEDICATED ACCESSORIES 66
7.4.1.1 IV POLES & MOUNTING EQUIPMENT 66
7.4.1.2 TUBING CLAMPS & SECUREMENT DEVICES 66
7.4.1.3 PORT PROTECTORS & DISINFECTION CAPS 66
7.4.1.4 PUMP BATTERIES & CHARGERS 67
7.4.1.5 PROTECTIVE COVERS 67
7.4.1.6 LABELS 67
7.4.1.7 TRACKING TOOLS 67
7.4.2 NON-DEDICATED ACCESSORIES 67
8 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY TYPE 68
8.1 OVERVIEW 69
8.2 TRADITIONAL INFUSION PUMPS 72
8.3 SPECIALITY INFUSION PUMPS 72
9 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY USAGE 73
9.1 OVERVIEW 74
9.2 DISPOSABLE 77
9.3 REUSABLE 77
10 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY INFUSION METHOD 78
10.1 OVERVIEW 79
10.2 INTRAVENOUS 82
10.3 SUBCUTANEOUS 82
10.4 EPIDURAL 82
10.5 ARTERIAL 82
11 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY INFUSION TYPE 83
11.1 OVERVIEW 84
11.2 CONTINOUS INFUSION 87
11.3 INTERMITTENT INFUSION 87
12 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY APPLICATION 88
12.1 OVERVIEW 89
12.2 GENERAL INFUSION 92
12.3 INSULIN INFUSION 92
12.4 CHEMOTHERAPY 92
12.5 PAIN & ANESTHESIA MANAGEMENT 92
12.6 GASTROENTEROLOGY 92
12.7 PEDIATRICS/NEONATOLOGY 92
12.8 HEMATOLOGY 92
12.9 ENTERAL INFUSION 93
12.10 OTHERS 93
13 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY OPERATION TYPE 94
13.1 OVERVIEW 95
13.2 SMART PUMP 98
13.3 SYRINGE PUMP 98
13.4 ELASTOMERIC PUMP 98
13.5 MULTI-CHANNEL PUMP 98
13.6 PERISTALTIC PUMP 98
14 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY END-USER 99
14.1 OVERVIEW 100
14.2 HOSPITALS & CLINICS 103
14.3 HOME HEALTHCARE 103
14.4 AMBULATORY AND SURGICAL CENTERS 103
14.5 OTHERS 103
15 DOMINICAN REPUBLIC INFUSION THERAPY MARKET, BY DISTRIBUTION CHANNEL 104
15.1 OVERVIEW 105
15.2 DIRECT TENDER 108
15.3 RETAIL SALES 108
15.4 OTHERS 108
16 DOMINICAN REPUBLIC INFUSION THERAPY MARKET 109
16.1 COMPANY SHARE ANALYSIS: DOMINICAN REPUBLIC 109
17 SWOT ANALYSIS 110
18 COMPANY PROFILES 111
18.1 MEDTRONIC 111
18.1.1 COMPANY SNAPSHOT 111
18.1.2 REVENUE ANALYSIS 112
18.1.3 PRODUCT PORTFOLIO 112
18.1.4 RECENT DEVELOPMENT 114
18.2 FRESENIUS KABI AG 115
18.2.1 COMPANY SNAPSHOT 115
18.2.2 REVENUE ANALYSIS 115
18.2.3 PRODUCT PORTFOLIO 116
18.2.4 RECENT DEVELOPMENTS 117
18.3 BAXTER 118
18.3.1 COMPANY SNAPSHOT 118
18.3.2 REVENUE ANALYSIS 118
18.3.3 PRODUCT PORTFOLIO 119
18.3.4 RECENT DEVELOPMENT 120
18.4 ICU MEDICAL, INC. 121
18.4.1 COMPANY SNAPSHOT 121
18.4.2 REVENUE ANALYSIS 121
18.4.3 PRODUCT PORTFOLIO 122
18.4.4 RECENT DEVELOPMENT 125
18.5 GE HEALTHCARE 126
18.5.1 COMPANY SNAPSHOT 126
18.5.2 REVENUE ANALYSIS 126
18.5.3 PRODUCT PORTFOLIO 127
18.6 APOTHECARIES SUNDRIES MFG. PVT. LTD. 131
18.6.1 COMPANY SNAPSHOT 131
18.6.2 PRODUCT PORTFOLIO 131
18.6.3 RECENT DEVELOPMENT 131
18.7 ARISS MEDICAL INC. 132
18.7.1 COMPANY SNAPSHOT 132
18.7.2 PRODUCT PORTFOLIO 132
18.7.3 RECENT DEVELOPMENT 132
18.8 AVANTE 133
18.8.1 COMPANY SNAPSHOT 133
18.8.2 PRODUCT PORTFOLIO 133
18.8.3 RECENT DEVELOPMENT 133
18.9 B.BRAUN SE. 134
18.9.1 COMPANY SNAPSHOT 134
18.9.2 REVENUE ANALYSIS 134
18.9.3 PRODUCT PORTFOLIO 135
18.9.4 RECENT DEVELOPMENT 136
18.10 BD 137
18.10.1 COMPANY SNAPSHOT 137
18.10.2 REVENUE ANALYSIS 138
18.10.3 PRODUCT PORTFOLIO 138
18.10.4 RECENT DEVELOPMENT 141
18.11 CHANGSHA SKYFAVOR MEDICAL DEVICES CO., LTD 142
18.11.1 COMPANY SNAPSHOT 142
18.11.2 PRODUCT PORTFOLIO 142
18.11.3 RECENT DEVELOPMENT 142
18.12 EPSIMED 143
18.12.1 COMPANY SNAPSHOT 143
18.12.2 PRODUCT PORTFOLIO 143
18.12.3 RECENT DEVELOPMENT 144
18.13 FARMACONAL 145
18.13.1 COMPANY SNAPSHOT 145
18.13.2 PRODUCT PORTFOLIO 145
18.13.3 RECENT DEVELOPMENT 145
18.14 GLOBAL HEALTH 146
18.14.1 COMPANY SNAPSHOT 146
18.14.2 PRODUCT PORTFOLIO 146
18.14.3 RECENT DEVELOPMENT 146
18.15 GRUPO HOSPIFAR 147
18.15.1 COMPANY SNAPSHOT 147
18.15.2 PRODUCT PORTFOLIO 147
18.15.3 RECENT DEVELOPMENT 147
18.16 HUNAN BEYOND MEDICAL TECHNOLOGY CO., LTD 148
18.16.1 COMPANY SNAPSHOT 148
18.16.2 PRODUCT PORTFOLIO 148
18.16.3 RECENT DEVELOPMENT 152
18.17 INSUMEDRD 153
18.17.1 COMPANY SNAPSHOT 153
18.17.2 PRODUCT PORTFOLIO 153
18.17.3 RECENT DEVELOPMENT 154
18.18 JAINCOLAB. 155
18.18.1 COMPANY SNAPSHOT 155
18.18.2 PRODUCT PORTFOLIO 155
18.19 KALSTEIN FRANCE - SIREN 158
18.19.1 COMPANY SNAPSHOT 158
18.19.2 PRODUCT PORTFOLIO 158
18.19.3 RECENT DEVELOPMENT 159
18.20 KORU MEDICAL SYSTEMS. 160
18.20.1 COMPANY SNAPSHOT 160
18.20.2 REVENUE ANALYSIS 160
18.20.3 PRODUCT PORTFOLIO 161
18.20.4 RECENT DEVELOPMENT 161
18.21 MEDZELL (EIGHTWE DIGITAL TRANSFORMATIONS PVT. LTD) 162
18.21.1 COMPANY SNAPSHOT 162
18.21.2 PRODUCT PORTFOLIO 162
18.21.3 RECENT DEVELOPMENT 163
18.22 MICREL MEDICAL DEVICES SA 164
18.22.1 COMPANY SNAPSHOT 164
18.22.2 PRODUCT PORTFOLIO 164
18.22.3 RECENT DEVELOPMENT 164
18.23 NAUGRA MEDICAL LAB 165
18.23.1 COMPANY SNAPSHOT 165
18.23.2 PRODUCT PORTFOLIO 165
18.23.3 RECENT DEVELOPMENT 166
18.24 STERNMED GMBH 167
18.24.1 COMPANY SNAPSHOT 167
18.24.2 PRODUCT PORTFOLIO 167
18.24.3 RECENT DEVELOPMENT 167
18.25 TELEFLEX INCORPORATED 168
18.25.1 COMPANY SNAPSHOT 168
18.25.2 REVENUE ANALYSIS 168
18.25.3 PRODUCT PORTFOLIO 169
18.25.4 RECENT DEVELOPMENT 169
18.26 TERUMO CORPORATION 170
18.26.1 COMPANY SNAPSHOT 170
18.26.2 REVENUE ANALYSIS 170
18.26.3 PRODUCT PORTFOLIO 171
18.26.4 RECENT DEVELOPMENT 171
18.27 VYGON 172
18.27.1 COMPANY SNAPSHOT 172
18.27.2 PRODUCT PORTFOLIO 172
18.27.3 RECENT DEVELOPMENT 173
19 QUESTIONNAIRE 174
20 RELATED REPORTS 178
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security